Trials / Withdrawn
WithdrawnNCT00396474
Safety Study In Patients Who Were Born Small And Short And Were Treated With Growth Hormone To Achieve Normal Height
Long-Term Metabolic Risk In Small for Gestational Age (SGA) Patients After Growth Hormone Treatment Compared To Matched, Untreated Controls
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to demonstrate that insulin sensitivity is not different between growth hormone - treated subjects who are small for gestational age (SGA) and an SGA cohort of subjects matched by gender and body mass index (BMI) who are not treated with growth hormone (GH) and who remain short at final height.
Detailed description
case-control
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | post GH treatment observational study | Intravenous glucose tolerance test (IVGTT) |
Timeline
- Start date
- 2009-01-01
- Completion
- 2012-01-01
- First posted
- 2006-11-07
- Last updated
- 2015-04-22
Source: ClinicalTrials.gov record NCT00396474. Inclusion in this directory is not an endorsement.